En fait c'est une étude publié dans un numéro de la revue "Cancer" et que l'agence Reuters rapporte que j'ai lu vitement. Il conclue que de faire un tel test diminue effectivement les chances de mourir du cancer de la vessie parce que le cancer est détecter plus tôt. Pour la commercialisation, je ne sais pas. Ce sont des bandes de papier qui détecte la présence de sang dans les urines, il me semble que ça pourrait se vendre mais est-ce déja fait et sous quel nom, il faudrait demander à notre étudiante en pharmacie, elle saurait peut-être plus que moi.
Posted: November 29, 2006
NEW YORK (Reuters Health) - Repetitive at-home urine screening for hemoglobin leads to early detection of bladder cancer, and may reduce mortality, according to study results published in the November 1st issue of Cancer.
"Bladder cancer is the sixth most common noncutaneous malignancy in the United States with more than 63,000 new diagnoses in 2005," Dr. Edward M. Messing, of the University of Rochester, New York, and colleagues point out.
The researchers investigated whether bladder cancer screening in healthy men could result in earlier detection of the disease and reduced mortality compared with men who were unscreened.
Of 3515 men at least 50 years of age who were solicited from well-patient clinic rosters in and around Madison, Wisconsin, 1575 men participated in the study. The men tested their urine repetitively with a chemical reagent strip for hemoglobin.
Over the course of the 19-year study, 258 (16.4%) men were evaluated for hematuria and 21 of them (8.1%) were diagnosed with bladder cancer.
The team compared cancer grades and stages and outcomes among men with bladder cancer detected by screening with that of 509 men with newly diagnosed bladder cancer who were reported to the Wisconsin Tumor Registry.
"The proportions of all newly diagnosed bladder cancers that were low-grade superficial, 52.4% in screenees and 60.7% in tumor registry cases, did not differ significantly (p = 0.50)," Dr. Messing and colleagues report. "The proportions of high-grade superficial or invasive cancers, 39.3% (unscreened) and 47.6% (screened), also were similar," they note.
However, 60% of high-grade unscreened cancers were muscle-invasive, whereas only 10% of high-grade tumors in screenees were muscle-invasive (p = 0.002), the researchers found.
None of the men with screen-detected bladder cancer had died at 14 years follow-up, whereas 20.4% of men with unscreened bladder cancer had died from the disease (p = 0.02).
The team concludes that home urine testing is a sensitive means of detecting bladder cancers, and "appears to improve survival from bladder cancer."